Cargando…
Sources of Cancer Neoantigens beyond Single-Nucleotide Variants
The success of checkpoint blockade therapy against cancer has unequivocally shown that cancer cells can be effectively recognized by the immune system and eliminated. However, the identity of the cancer antigens that elicit protective immunity remains to be fully explored. Over the last decade, most...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455963/ https://www.ncbi.nlm.nih.gov/pubmed/36077528 http://dx.doi.org/10.3390/ijms231710131 |